Tryptase loss-of-function mutations reduce tryptase expression and predict asthmatic response to anti-IgE therapy

类胰蛋白酶 医学 免疫球蛋白E 免疫学 肥大细胞 抗体
作者
David F. Choy,Neil N. Trivedi,Amy Dressen,Magda Babina,Rahul Ahuja,Tangsheng Yi,Janet K. Jackman,Guiquan Ji,Jason A. Hackney,Luz Orozco Guerra,Diana Chang,George H. Caughey,Brian L. Yaspan
出处
期刊:The European respiratory journal [European Respiratory Society]
卷期号:: OA1652-OA1652 被引量:2
标识
DOI:10.1183/13993003.congress-2018.oa1652
摘要

Background: Tryptase is a major mast cell product implicated in asthma by promoting bronchoconstriction and stromal cell hyperplasia. Loss-of-function mutations in genes TPSAB1 and TPSB2 encoding tryptases are common in ethnically diverse populations. We hypothesized that these mutations decrease tryptase activity and predict asthmatic clinical response to anti-IgE therapy. Objective: To understand the relationship of tryptase loss-of-function mutations with mast cell tryptase activity ex vivo, circulating tryptase levels, and clinical response to anti-IgE therapy. Methods: Active tryptase allele count was determined by direct sequencing of TPSAB1 and TPSB2 genes and counting functional alleles. Tryptase activity was measured by enzymatic assay in human foreskin mast cell lysates. Total tryptase in serum/plasma was assessed by ELISA. Post hoc pharmacogenetic analysis was conducted of the EXTRA study (NCT00314574), a double-blind placebo controlled study of allergic moderate to severe asthmatics treated with Xolair (anti-IgE). Results: Active tryptase allele count correlated with 1) tryptase activity in primary mast cells (P<0.05, N=101 donors), 2) circulating tryptase levels in two studies of severe asthma (P<0.001, N=105 and N=36), and 3) FEV1% improvement in asthmatics treated with Xolair when comparing subjects with 1 or 2 versus 3 or 4 active alleles (P<0.05 interaction test, N=309, FEV1% improvement 11.3[3,19.6]% and -0.7[-7.1,5.7]% respectively). Conclusion: Active tryptase allele count determines expression of functional tryptase and may predict clinical outcomes for therapeutic strategies for asthma directed at mast cells.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
Iris发布了新的文献求助10
2秒前
调皮彤发布了新的文献求助10
2秒前
初景的应助被Dawn采纳,获得20
3秒前
领导范儿的应助被Eli采纳,获得100
4秒前
5秒前
拜见小山大王完成签到,获得积分10
6秒前
所所的应助被Tuniverse_采纳,获得10
7秒前
酷炫冷卉完成签到 ,获得积分10
7秒前
汉堡包的应助被朴实的访曼采纳,获得10
8秒前
9秒前
152455发布了新的文献求助10
10秒前
11秒前
11秒前
寒冷的饼干完成签到 ,获得积分10
11秒前
12秒前
烟花的应助被DODO采纳,获得10
12秒前
学术文献互助的应助被辛未采纳,获得200
12秒前
Maestro_S的应助被辛未采纳,获得10
12秒前
Maestro_S的应助被辛未采纳,获得10
12秒前
maguodrgon发布了新的文献求助50
12秒前
科研通AI6.4的应助被dummer采纳,获得10
13秒前
小雨发布了新的文献求助200
13秒前
15秒前
十八与雨完成签到,获得积分10
15秒前
虚心的小周完成签到,获得积分10
16秒前
李林泽发布了新的文献求助10
16秒前
16秒前
17秒前
情怀的应助被VitoLi采纳,获得10
17秒前
Elisa完成签到 ,获得积分10
17秒前
17秒前
一盒火柴发布了新的文献求助10
18秒前
18秒前
大个的应助被Tuniverse_采纳,获得10
19秒前
orixero的应助被科研通管家采纳,获得10
19秒前
传奇3的应助被liyun采纳,获得10
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170866
求助须知:如何正确求助?哪些是违规求助? 9563691
关于积分的说明 21771699
捐赠科研通 7762353
什么是DOI,文献DOI怎么找? 3430767
关于科研通互助平台的介绍 2554622
邀请新用户注册赠送积分活动 2475597